Cholesterol and Coronary Heart Disease: New Data from the Woscop Study

By Poli A.  

Pharmacological Research, Vol. 35, Iss. 3, 1997-03 ,pp. : 171-172

Academic Press

Access to resources Recommend Favorite

Secondary Prevention in Coronary Heart Disease: Goal Achievement and Drug Prescribing

By Giverhaug Trude   Bruland Christine   Trovik Thor  

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 472-474

Springer Publishing Company

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart Disease: Evaluative Study Carried Out in Spain

By Plans-Rubió P.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 623-643

Adis International

Access to resources Recommend Favorite

Intervention with Clarithromycin in Patients with Stable Coronary Heart Disease

By  

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 14-19

Karger

Access to resources Recommend Favorite

The need for pharmaceutical care in the prevention of coronary heart disease: an exploratory study in acute myocardial infarction patients

By Chinwong Surarong   Reid Fiona   McGlynn Steve   Hudson Steve   Flapan Andy  

Pharmacy World and Science, Vol. 26, Iss. 2, 2004-04 ,pp. : 96-101

Springer Publishing Company

Access to resources Recommend Favorite